107 related articles for article (PubMed ID: 23808164)
1. [Dimeric bisberzimidazoles: cytotoxicity and effects on DNA methylation in normal and cancer human cells].
Dariĭ MV; Rakhimova AR; Tashlitskiĭ VN; Kostiuk SV; Veĭko NN; Ivanov AA; Zhuze AL; Gromova ES
Mol Biol (Mosk); 2013; 47(2):292-301. PubMed ID: 23808164
[TBL] [Abstract][Full Text] [Related]
2. [DNA sequence-specific ligands: XIV. Synthesis of fluorescent biologicaly active dimeric bisbenzimidazoles-DB(3, 4, 5, 7, 11)].
Ivanov AA; Salianov VI; Strel'tsov SA; Cherepanova NA; Gromova ES; Zhuze AL
Bioorg Khim; 2011; 37(4):530-41. PubMed ID: 22096996
[TBL] [Abstract][Full Text] [Related]
3. Dimeric bisbenzimidazoles inhibit the DNA methylation catalyzed by the murine Dnmt3a catalytic domain.
Cherepanova NA; Ivanov AA; Maltseva DV; Minero AS; Gromyko AV; Streltsov SA; Zhuze AL; Gromova ES
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):295-300. PubMed ID: 20615081
[TBL] [Abstract][Full Text] [Related]
4. Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells.
Kostyuk SV; Kvasha MA; Khrabrova DA; Kirsanova OV; Ershova ES; Malinovskaya EM; Veiko NN; Ivanov AA; Koval VS; Zhuze AL; Tashlitsky VH; Umriukhin PE; Kutsev SI; Gromova ES
PLoS One; 2018; 13(1):e0189826. PubMed ID: 29329300
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and demethylation as targets for anticancer therapy.
Szyf M
Biochemistry (Mosc); 2005 May; 70(5):533-49. PubMed ID: 15948707
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase inhibition may limit cancer cell growth by disrupting ribosome biogenesis.
Moss T
Epigenetics; 2011 Feb; 6(2):128-33. PubMed ID: 20935488
[TBL] [Abstract][Full Text] [Related]
9. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer.
Li YC; Wang Y; Li DD; Zhang Y; Zhao TC; Li CF
J Cell Biochem; 2018 Feb; 119(2):2440-2449. PubMed ID: 28926119
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and cancer therapy.
Szyf M
Drug Resist Updat; 2003 Dec; 6(6):341-53. PubMed ID: 14744498
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S
Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
13. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
14. Novel anticancer drug curaxin CBL0137 impairs DNA methylation by eukaryotic DNA methyltransferase Dnmt3a.
Sergeev A; Vorobyov A; Yakubovskaya M; Kirsanova O; Gromova E
Bioorg Med Chem Lett; 2020 Aug; 30(16):127296. PubMed ID: 32631516
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer.
Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z
Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263
[TBL] [Abstract][Full Text] [Related]
16. Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma.
Zhao SL; Zhu ST; Hao X; Li P; Zhang ST
Dis Esophagus; 2011 Nov; 24(8):601-10. PubMed ID: 21539677
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
18. Function of DNA methyltransferase 3a in lead (Pb(2+) )-Induced Cyclooxygenase-2 gene.
Tsai YT; Chang CM; Wang JY; Hou MF; Wang JM; Shiurba R; Chang WC; Chang WC
Environ Toxicol; 2015 Sep; 30(9):1024-32. PubMed ID: 24639330
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of HeLa cells upon DNMT3L overexpression mimics carcinogenesis.
Gokul G; Ramakrishna G; Khosla S
Epigenetics; 2009 Jul; 4(5):322-9. PubMed ID: 19625766
[TBL] [Abstract][Full Text] [Related]
20. Minor groove dimeric bisbenzimidazoles inhibit in vitro DNA binding to eukaryotic DNA topoisomerase I.
Susova OY; Ivanov AA; Morales Ruiz SS; Lesovaya EA; Gromyko AV; Streltsov SA; Zhuze AL
Biochemistry (Mosc); 2010 Jun; 75(6):695-701. PubMed ID: 20636260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
